ASTS
AST SpaceMobile, Inc.
ASTS lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to grow, though they disagree widely on how much.
PHUN
Phunware, Inc.
There isn't enough reported data to score PHUN yet.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
PHUN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
PHUN's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
PHUN PE Valuation
PHUN has no meaningful PE right now: it lost money over the past year.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
PHUN Forward outlook
There aren't enough analyst estimates for PHUN to show an outlook.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
PHUN has the stronger earnings trend. Trailing diluted EPS is down 273% for ASTS versus PHUN down 104%.
PHUN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2024 | -$10.08 | +$8.42 |
| Q2 2024 | -$17.83 | -$3.33 |
| Q1 2024 | -$20.51 | -$0.51 |
| Q4 2023 | -$22.18 | +$3.32 |
| Q3 2023 | -$18.50 | +$20.50 |
| Q2 2023 | -$14.50 | +$20.50 |
| Q1 2023 | -$20.00 | +$12.50 |
| Q4 2022 | -$25.50 | +$9.00 |
PHUN is still losing money, but far less than before: $0.65 per share over the past year, against $39.00 at its worst in late 2022.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over PHUN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS has the edge over PHUN on profitability, with a higher operating margin.
PHUN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $799K | +76% |
| Q1 2026 | $542K | -21% |
| Q4 2025 | $788K | +33% |
| Q3 2025 | $622K | -6.5% |
| Q2 2025 | $455K | -55% |
| Q1 2025 | $688K | -25% |
| Q3 2024 | $665K | -76% |
| Q2 2024 | $1M | -71% |
PHUN's revenue is recovering but still below its 2022 peak: $799,000 last quarter, up 76% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -757% | +179 points |
| Q1 2026 | -742% | -42 points |
| Q4 2025 | -1008% | -182 points |
| Q3 2025 | -563% | -83 points |
| Q2 2025 | -936% | -646 points |
| Q1 2025 | -700% | -388 points |
| Q4 2024 | -826% | N/A |
| Q3 2024 | -480% | +184 points |
PHUN's operating margin was โ757% last quarter, up 179 points from the same quarter a year ago.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: โ$1.8B over the past year, against โ$916M the year before.
PHUN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$5.7M | -$2.3M |
| Q1 2026 | -$2.7M | +$608K |
| Q4 2025 | -$3.2M | -$484K |
| Q3 2025 | -$2.5M | -$96K |
| Q2 2025 | -$3.5M | -$780K |
| Q1 2025 | -$3.3M | +$2.2M |
| Q4 2024 | -$2.7M | -$146K |
| Q3 2024 | -$2.4M | +$924K |
PHUN has the edge over ASTS on cash flow, with more consistent year-over-year improvement.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
PHUN Net Leverage
PHUN's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
PHUN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 15.3 | Oversold |
PHUN's weekly RSI is 34 (neutral) and its Stochastic is 15 (oversold).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
PHUN PE vs Technology Sector
PHUN has no meaningful PE right now: it lost money over the past year.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has the edge over PHUN on trend strength, trading above more of its moving averages.
PHUN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1.93 | 9.8% below |
| 20 week MA | $2.02 | 14% below |
| 50 week MA | $1.96 | 11% below |
| 100 week MA | $2.56 | 32% below |
| 200 week MA | $8.89 | 80% below |
PHUN is in a downtrend: it's below all five of its weekly moving averages, and 80% below its 200-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to โ54% in 2022. It's down 52% so far in 2026.
PHUN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $59.0 | $50.5 | -14% |
| 2021 | $50.5 | $153.0 | +203% |
| 2022 | $153.0 | $39.1 | -74% |
| 2023 | $39.1 | $4.10 | -90% |
| 2024 | $4.10 | $5.73 | +40% |
| 2025 | $5.73 | $1.92 | -66% |
| 2026 YTD | $1.92 | $1.74 | -9.4% |
PHUN has the edge over ASTS on returns for 2026, with the stronger performance.